Last thursday, over 20 healthcare stakeholders, experts and politicians gather in Stockholm for a round table discussion on increasing collaboration on cross-border cancer research and innovation between Sweden and the United States, in order to improve patient outcomes.
The roundtable was hosted by the U.S. Ambassador Azita Raji and the Swedish Minister for Higher Education and Research, Helene Hellmark Knutsson, in collaboration with the biopharma company Bristol-Myers Squibb (BMS).
In September, the Minister for Higher Education and Research, Helene Hellmark Knutsson, signed an agreement on bilateral cancer research cooperation between the United States and Sweden. The agreement is a part of the “Cancer Moonshot” initiative led by U.S. Vice President Joe Biden, with the mission of ultimately eradicating cancer. The BMS foundation supports the Cancer Moonshot in the U.S. and has now decided to take an active role in the Swedish work around the Cancer Moonshot initiative. Today’s roundtable is the first meeting within that context.
Cancer Moonshot
During his 2016 State of the Union Address, President Obama called on Vice President Biden to lead a new, national ”Cancer Moonshot” focused on making a decade of progress in preventing, diagnosing, and treating cancer in 5 years, ultimately striving to end cancer as we know it. BMS Foundation is funding “Cancer Moonshot” with $25 million.
Photo: David Lienemann
